Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
EV/Core EBITDA

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 9.319.987.267.948.95

What is the latest EV/Core EBITDA ratio of AUROBINDO PHARMA ?

The latest EV/Core EBITDA ratio of AUROBINDO PHARMA is 9.31 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20259.31
Mar20249.98
Mar20237.26
Mar20227.94
Mar20218.95

How is EV/Core EBITDA of AUROBINDO PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 9.31
-6.71
Mar2024 9.98
37.47
Mar2023 7.26
-8.56
Mar2022 7.94
-11.28
Mar2021 8.95 -

Other Financial Ratios of AUROBINDO PHARMA


Compare EV/Core EBITDA ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹60,115.7 Cr 0.6% -4.1% -35.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹378,999.0 Cr -0.4% -3% -14.1% Stock Analytics
DIVIS LABORATORIES ₹163,635.0 Cr 0.6% -3.1% 20.2% Stock Analytics
CIPLA ₹127,544.0 Cr 0% 5.2% -5.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,050.0 Cr 0.8% -1.9% 2.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,373.0 Cr 0.1% 3.5% -10.6% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

0.6%

-4.1%

-35.2%

SENSEX

-0.3%

-0.8%

-1.9%


You may also like the below Video Courses